Randomized Prospective Trial Exploring the Impact of Structured Journaling in Patients With Sarcoma on the Management of Treatment-Related Adverse Events.

N J SpeeceMeng Lin Xu Gabriel Tinoco David A Liebner James L Chen

Published in: JCO oncology practice (2021)

To our knowledge, this is the first prospective randomized trial evaluating the use of structured journaling as a low-cost means to improve treatment-related adverse event management and QOL in patients with sarcoma undergoing SACT. These promising results will need to be confirmed by additional studies.

Keyphrases

low cost
phase iii
clinical trial
phase ii
open label
study protocol
emergency department
double blind
replacement therapy
adverse drug